Next Generation Blood Gas Monitors System Market

Next Generation Blood Gas Monitors are the devices used for monitoring the level of arterial oxygen tension (pO2), carbon dioxide tension (pCO2), and acidity (pH), these parameters assist in disease diagnosis such as shock, overdose of a particular drug, pulmonary disorder etc. The Next Generation Blood Gas Monitors are vital devices for CCU and ICU rooms in the hospital.

Next Generation Blood Gas Monitors System Market contains market size and forecasts of Next Generation Blood Gas Monitors System in global, including the following market information:

• Global Next Generation Blood Gas Monitors System Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Next Generation Blood Gas Monitors System Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Next Generation Blood Gas Monitors System companies in 2021 (%)

The global Next Generation Blood Gas Monitors System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bench Top Blood Gas Monitors System Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Next Generation Blood Gas Monitors System include Medica, Bayer, Radiometer Medical, Convergent, Abbott Point of Care, Nova Biomedical, Roche, Siemens and Samsung, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Next Generation Blood Gas Monitors System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Next Generation Blood Gas Monitors System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Next Generation Blood Gas Monitors System Market Segment Percentages, by Type, 2021 (%)

• Bench Top Blood Gas Monitors System
• Portable Blood Gas Monitors System

Global Next Generation Blood Gas Monitors System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Next Generation Blood Gas Monitors System Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cardiac Centers
• Clinical Laboratories
• Others

Global Next Generation Blood Gas Monitors System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Next Generation Blood Gas Monitors System Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Next Generation Blood Gas Monitors System revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Next Generation Blood Gas Monitors System revenues share in global market, 2021 (%)
• Key companies Next Generation Blood Gas Monitors System sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Next Generation Blood Gas Monitors System sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medica
• Bayer
• Radiometer Medical
• Convergent
• Abbott Point of Care
• Nova Biomedical
• Roche
• Siemens
• Samsung
• Erba
• Dalko Diagnostics
• Edan Instruments, Inc.
• Easy Diagnosis Biomedicine
• Wondfo Biotech
• Getein Biotech
• Sinocare Inc.